Caixin
Aug 28, 2022 08:00 AM

Guangdong Vtr Bio-Tech Co.,Ltd.’s Net Profit Dropped 62.9% in First Half of 2022

Guangdong Vtr Bio-Tech Co.,Ltd. (广东溢多利生物科技股份有限公司) (300381.SZ) reported a net profit of 28.6 million yuan in the first half of 2022, down 62.9% year-on-year.

Meanwhile, the company posted 753.9 million yuan in revenue, down 13.5% year-on-year.

At the end of the reporting period, it had 3.1 billion yuan in total assets and 275 million yuan in total liabilities, with a liability-to-asset ratio of 8.9%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Business Uncovered Podcast: Inside Vanke and China’s Property Reckoning
00:00
00:00/00:00